Racial disparities in patients with TP53 mutated acute myeloid leukemia.

被引：0
|
作者：
Badar, Talha
Litzow, Mark Robert
Shallis, Rory
Stahl, Maximilian
Bewersdorf, Jan Philipp
Saliba, Antoine N.
Correia, Guilherme Sacchi De Camargo
Patel, Anand Ashwin
Abaza, Yasmin
Murthy, Guru Subramanian Guru
Duvall, Adam
Burkart, Madelyn
Al-Kali, Aref
Palmisiano, Neil
Dinner, Shira
Goldberg, Aaron David
Atallah, Ehab L.
机构：
[1] Mayo Clin, Jacksonville, FL USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
[3] Yale Sch Med, New Haven, CT USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY USA
[5] Yale Univ Sch Med, New Haven, CT USA
[6] Mt Sanai Hosp, New York, NY USA
[7] Univ Chicago, Chicago, IL USA
[8] Northwestern Mem Hosp, Chicago, IL USA
[9] Med Coll Wisconsin, Div Hematol Oncol, Milwaukee, WI USA
[10] Univ Chicago Med, Chicago, IL USA
[11] Thomas Jefferson Univ Hosp, Philadelphia, PA USA
[12] Med Coll Wisconsin, Milwaukee, WI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19007
引用
收藏
页码：E19007 / E19007
页数：1
相关论文
共 50 条
  • [11] Activity of venetoclax-based therapy in TP53-mutated acute myeloid leukemia.
    Shoukier, Mahran
    Konopleva, Marina
    Dinardo, Courtney Denton
    Ravandi, Farhad
    Andreeff, Michael
    Garcia-Manero, Guillermo
    Jabbour, Elias
    Daver, Naval Guastad
    Borthakur, Gautam
    Pemmaraju, Naveen
    Montalban-Bravo, Guillermo
    Benton, Christopher Brent
    Short, Nicholas James
    Bhalla, Kapil N.
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    Kadia, Tapan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [12] TP53-Mutated Myelodysplasia and Acute Myeloid Leukemia
    Testa, Ugo
    Castelli, Germana
    Pelosi, Elvira
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2023, 15 (01)
  • [13] TP53-mutated Acute Myeloid Leukemia with Myelodysplasia-Related Changes and TherapyRelated Acute Myeloid Leukemia Have Comparable TP53 Mutational Signature and Clinical Features
    Tashakori, Mehrnoosh
    Tapan, Kadia
    Loghavi, Sanam
    Tang, Zhenya
    Routbort, Mark
    Ravandi-Kashani, Farhad
    Khoury, Joseph
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1027 - 1028
  • [14] Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine
    Bories, Pierre
    Prade, Nais
    Lagarde, Stephanie
    Cabarrou, Bastien
    Largeaud, Laetitia
    Plenecassagnes, Julien
    Luquet, Isabelle
    De Mas, Veronique
    Filleron, Thomas
    Cassou, Manon
    Sarry, Audrey
    Fornecker, Luc-Matthieu
    Simand, Celestine
    Bertoli, Sarah
    Recher, Christian
    Delabesse, Eric
    PLOS ONE, 2020, 15 (10):
  • [15] Evolutionary Action (EA) Score of TP53 Mutations Defines Prognostic Subsets within TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia
    Kanagal-Shamanna, Rashmi
    Montalban-Bravo, Guillermo
    Class, Caleb
    Sasaki, Koji
    Benton, Christopher B.
    Soltysiak, Kelly
    Jabbour, Elias
    Kadia, Tapan M.
    Bueso-Ramos, Carlos E.
    Patel, Keyur P.
    Routbort, Mark
    Ganan-Gomez, Irene
    Wei, Yue
    Borthakur, Gautam M.
    Ravandi, Farhad
    Do, Kim-Anh
    Medeiros, L. Jeffrey
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    BLOOD, 2019, 134
  • [16] TP53 mutations in older adults with acute myeloid leukemia
    Yanada, Masamitsu
    Yamamoto, Yukiya
    Iba, Sachiko
    Okamoto, Akinao
    Inaguma, Yoko
    Tokuda, Masutaka
    Morishima, Satoko
    Kanie, Tadaharu
    Mizuta, Shuichi
    Akatsuka, Yoshiki
    Okamoto, Masataka
    Emi, Nobuhiko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 103 (04) : 429 - 435
  • [17] The role of TP53 in acute myeloid leukemia: Challenges and opportunities
    Barbosa, Karina
    Li, Sha
    Adams, Peter D.
    Deshpande, Aniruddha J.
    GENES CHROMOSOMES & CANCER, 2019, 58 (12) : 875 - 888
  • [18] TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia
    Rahme, Ramy
    Braun, Thorsten
    Manfredi, James J.
    Fenaux, Pierre
    BIOMEDICINES, 2023, 11 (04)
  • [19] TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
    Welch, J. S.
    Petti, A. A.
    Miller, C. A.
    Fronick, C. C.
    O'Laughlin, M.
    Fulton, R. S.
    Wilson, R. K.
    Baty, J. D.
    Duncavage, E. J.
    Tandon, B.
    Lee, Y-S
    Wartman, L. D.
    Uy, G. L.
    Ghobadi, A.
    Tomasson, M. H.
    Pusic, I.
    Romee, R.
    Fehniger, T. A.
    Stockerl-Goldstein, K. E.
    Vij, R.
    Oh, S. T.
    Abboud, C. N.
    Cashen, A. F.
    Schroeder, M. A.
    Jacoby, M. A.
    Heath, S. E.
    Luber, K.
    Janke, M. R.
    Hantel, A.
    Khan, N.
    Sukhanova, M. J.
    Knoebel, R. W.
    Stock, W.
    Graubert, T. A.
    Walter, M. J.
    Westervelt, P.
    Link, D. C.
    DiPersio, J. F.
    Ley, T. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (21) : 2023 - 2036
  • [20] Acute myeloid leukemia with TP53 germ line mutations
    Zebisch, Armin
    Lal, Ridhima
    Mueller, Marian
    Lind, Karin
    Kashofer, Karl
    Girschikofsky, Michael
    Fuchs, David
    Woelfler, Albert
    Geigl, Jochen B.
    Sill, Heinz
    BLOOD, 2016, 128 (18) : 2270 - 2272
12345